- Home
- MKSI vs PCVX Comparison
MKSI vs PCVX Comparison
Compare MKSI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKSI
- PCVX
- Stock Information
- Founded
- MKSI 1961
- PCVX 2013
- Country
- MKSI United States
- PCVX United States
- Employees
- MKSI N/A
- PCVX N/A
- Industry
- MKSI Industrial Machinery/Components
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- MKSI Industrials
- PCVX Health Care
- Exchange
- MKSI Nasdaq
- PCVX Nasdaq
- Market Cap
- MKSI 5.0B
- PCVX 4.4B
- IPO Year
- MKSI 1999
- PCVX 2020
- Fundamental
- Price
- MKSI $101.31
- PCVX $33.10
- Analyst Decision
- MKSI Buy
- PCVX Strong Buy
- Analyst Count
- MKSI 11
- PCVX 10
- Target Price
- MKSI $131.73
- PCVX $136.50
- AVG Volume (30 Days)
- MKSI 946.5K
- PCVX 1.5M
- Earning Date
- MKSI 08-06-2025
- PCVX 08-05-2025
- Dividend Yield
- MKSI 0.87%
- PCVX N/A
- EPS Growth
- MKSI N/A
- PCVX N/A
- EPS
- MKSI 3.36
- PCVX N/A
- Revenue
- MKSI $3,654,000,000.00
- PCVX N/A
- Revenue This Year
- MKSI $7.00
- PCVX N/A
- Revenue Next Year
- MKSI $6.70
- PCVX N/A
- P/E Ratio
- MKSI $30.00
- PCVX N/A
- Revenue Growth
- MKSI N/A
- PCVX N/A
- 52 Week Low
- MKSI $54.84
- PCVX $27.66
- 52 Week High
- MKSI $147.40
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- MKSI 64.57
- PCVX 42.61
- Support Level
- MKSI $98.21
- PCVX $32.06
- Resistance Level
- MKSI $100.80
- PCVX $33.81
- Average True Range (ATR)
- MKSI 2.69
- PCVX 1.23
- MACD
- MKSI 0.41
- PCVX -0.16
- Stochastic Oscillator
- MKSI 84.67
- PCVX 8.44
About MKSI MKS Instruments Inc.
MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.